Tenet Healthcare (NYSE: THC) CIO sells 10,878 shares at $243.90 average

Rhea-AI Filing Summary

Tenet Healthcare Corp executive Paola M. Arbour, EVP and Chief Information Officer, sold 10,878 shares of common stock on July 27, 2026 in a transaction reported as a sale in open market or private transactions at a weighted average price of $243.90 per share, with individual prices ranging from $243.82 to $244.08. Following this sale, she directly holds 18,413 shares of Tenet Healthcare common stock. The transaction was not marked as made under a Rule 10b5-1 trading plan.

Insider Trade Summary

Net Seller: 10,878 shares

Net Sell 1 txn

Insider Arbour Paola M

Role EVP, Chief Information Officer

Sold 10,878 shs ($2.65M)

Type	Security	Shares	Price	Value
Sale	Common Stock F1	10,878	$243.90	$2.65M

Holdings After Transaction: Common Stock — 18,413 shares (Direct)

Footnotes (1)

1. F1. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $243.82 to $244.08. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Key Figures

Shares sold: 10,878 shares Weighted average sale price: $243.90 per share Sale price range: $243.82–$244.08 per share +1 more

4 metrics

Shares sold 10,878 shares Common Stock sold by Paola M. Arbour on July 27, 2026

Weighted average sale price $243.90 per share Average price across multiple sale transactions

Sale price range $243.82–$244.08 per share Range of prices for individual trades within the aggregated sale

Shares owned after transaction 18,413 shares Direct ownership by Paola M. Arbour following the sale

Key Terms

weighted average sales price, open market or private transaction, Securities and Exchange Commission

3 terms

weighted average sales price financial

"The price is the weighted average sales price of the aggregate number of shares"

open market or private transaction regulatory

"transaction_code_description: Sale in open market or private transaction"

Securities and Exchange Commission regulatory

"the staff of the Securities and Exchange Commission, upon request, full information"

A national government agency that enforces rules for buying, selling and disclosing information about stocks and other investments, acting like a referee and scorekeeper for financial markets. It requires companies to share clear, regular financial and business information and investigates fraud or rule-breaking, which matters to investors because those rules and disclosures help ensure fair prices, reduce hidden risks and make it easier to compare investment choices.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/28/2026 - 08:00 PM Accepted by SEC EDGAR 07/28/2026 - 08:00 PM Learn about SEC filing dates

FAQ

What insider transaction did Tenet Healthcare (THC) report for Paola M. Arbour?

Tenet Healthcare reported that EVP and Chief Information Officer Paola M. Arbour sold 10,878 shares of common stock on July 27, 2026. The sale was reported as an open market or private transaction at a weighted average price of $243.90 per share.

At what price did Paola M. Arbour sell Tenet Healthcare (THC) shares?

Paola M. Arbour sold Tenet Healthcare shares at a weighted average price of $243.90 per share. According to the disclosure, individual transaction prices ranged from $243.82 to $244.08, reflecting multiple trades aggregated into the reported average price.

How many Tenet Healthcare (THC) shares does Paola M. Arbour own after the sale?

After the reported sale, Paola M. Arbour directly holds 18,413 shares of Tenet Healthcare common stock. This figure reflects her direct ownership position immediately following the 10,878-share disposition disclosed for July 27, 2026.

Was Paola M. Arbour’s Tenet Healthcare (THC) share sale under a Rule 10b5-1 plan?

The transaction was not marked as made under a Rule 10b5-1 trading plan. The Rule 10b5-1 checkbox associated with the reported sale was not selected, indicating it was not designated as a pre-arranged trading plan transaction.

What does the price range mean in Paola M. Arbour’s Tenet Healthcare (THC) sale?

The disclosure states the reported $243.90 price is a weighted average. The 10,878 shares were sold in multiple trades at prices between $243.82 and $244.08, with detailed per-trade pricing available from the company or the insider upon request.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Arbour Paola M

(Last) (First) (Middle)

14201 DALLAS PARKWAY

(Street)

DALLAS TEXAS 75254

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
TENET HEALTHCARE CORP [ THC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Information Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/27/2026		S		10,878	D	$243.9(1)	18,413	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $243.82 to $244.08. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

	Chad J. Wiener, as Attorney-in-fact for Paola M. Arbour	07/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)